Major Depressive Disorder monitoring system: development of a platform based on wearable devices in relevant scenarios – PDC2022-133197-I00
- Post by: Grupo del I3A
- 3 febrero 2023
- Comments off
Eduardo Gil & Raquel Bailón
Ministerio de Ciencia e Innovación
Major depressive disorder (MDD) affects 7% of adult population in Europe every year. MDD is associated with increased risk of cardiovascular morbidity and mortality, and it is a major cause of disability and loss of quality of life. Depression represents high costs for the Health System, including direct (medical treatment, care and rehabilitation) and indirect (work disability and loss of productivity) nature. One of the main challenges in depression remains the monitoring of disease evolution, which is of paramount importance in recurrent and treatment-resistant depression.